AI in Medicine
👤 Dr. Emily Carter¹, 👤 Dr. Michael Brown²
¹ Department of Molecular Biology, Cambridge University, United Kingdom
² Institute of Biomedical Research, Standford University, USA
📆 May 10, 2024 • 📝 Vol 4, Issue 2 • 🔗️ DOI: 10.1234/fj.2024.04201 • 👁️1,245 Views
- Abstract
- Full Text
- Figures
- References
- Metrics
- Keywords
Abstract
Gene editing technologies have rapidly evolved over the past decade, revolutionizing biomedical research and therapeutic development. This paper reviews recent advances in CRISPR-Cas systems, base editing, and prime editing, and discusses their potential applications in treating genetic disorders, cancer, and infectious diseases. We also examine the ethical, regulatory, and safety considerations that must guide the future clinical translation of these powerful tools.
Keywords: Gene Editing, CRISPR-Cas9, Base Editing, Prime Editing, Genome Engineering, Future Medicine
1. Introduction
The ability to precisely modify genomic sequences has transformed the landscape of modern medicine. Among the various tools developed, CRISPR-Cas systems have emerged as the most versatile and widely used. This paper provides an overview of current gene editing technologies and their implications for future medical applications.
2. Advances in Gene Editing Technologies
2.1 CRISPR-Cas Systems CRISPR-Cas9 remains the most widely used gene editing tool due to its simplicity and efficiency. Recent improvements have increased its specificity and expanded its target range.
2.2 Base Editing Base editors enable precise nucleotide conversions without introducing double-strand breaks, reducing undesired mutations and improving safety.
2.3 Prime Editing Prime editing is a novel technology that allows precise insertions, deletions, and all types of base substitutions with high accuracy.
3. Implications for Future Medicine
These technologies hold promise for treating inherited diseases, developing personalized therapies, and addressing previously untreatable conditions.
4. Challenges and Ethical Considerations
Off-target effects, long-term safety, and ethical concerns related to germline editing remain major challenges that require global regulatory oversight.
5. Conclusion
Gene editing technologies have the potential to revolutionize medicine, but responsible research, ethical governance, and rigorous clinical evaluation are essential for their safe and equitable application.
1. Introduction
Gene editing technologies have transformed modern biomedical research by enabling precise modifications to genetic material. These innovations have opened new possibilities for understanding genetic diseases, developing targeted therapies, and advancing personalized medicine.
2. Advances in Gene Editing Technologies
2.1 CRISPR-Cas Systems CRISPR-Cas9 remains the most widely used gene editing tool due to its simplicity and efficiency. Recent improvements have increased its specificity and expanded its target range.
2.2 Base Editing Base editors enable precise nucleotide conversions without introducing double-strand breaks, reducing undesired mutations and improving safety.
2.3 Prime Editing Prime editing is a novel technology that allows precise insertions, deletions, and all types of base substitutions with high accuracy.
Figures (3)
Figure 1: Overview of CRISPR-Cas9 gene-editing mechanism
Figure 2: Comparison of base editing and prime editing techniques
Figure 3: Potential clinical applications of gene-editing technologies
References (45)
(Sample – you may expand to 45)
- Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science.
- Anzalone, A. V., et al. (2019). Search-and-replace genome editing without double-strand breaks. Nature.
- Komor, A. C., et al. (2016). Programmable editing of a target base in genomic DNA. Nature.
- Hsu, P. D., et al. (2014). Development and applications of CRISPR-Cas9. Cell.
(…continue until Reference 45)
Metrics
- Views: 1,245
- Downloads: 320
- Citations: 18
- Altmetric Score: 42
- Last Updated: May 10, 2024
Keywords
- Gene Editing
- CRISPR-Cas9
- Base Editing
- Prime Editing
- Genome Engineering
- Precision Medicine
- Biomedical Innovation
- Genetic Disorders
- Therapeutic Applications
Author Information
Dr. Emily Carter
Department of Molecular Biology, Cambridge University, United Kingdom
Email: emily.carter@cam.ac.uk
Dr. Michael Brown
Institute of Biomedical Research, Standford University, USA
Email: michael.brown@standford.edu
Declarations
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
Data Availability: Data sharing is not applicable to this article as no datasets were generated or analyzed.
Ethics Approval: Not Applicable
How to Cite This Article
Carter, E,, & Brown , M. (2024), Advances in Gene Editing Technologies: Implications for Future Medicine. Foresea Journal, 4(2), 15-28, https://doi.org/10.1234/fj.2024.04201
